Search Within

Alison Moskowitz

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (123)
  2. Journal Article (83)
  3. Research Letter (7)
  4. Review (5)
  5. Correspondence (1)
  6. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (220)
  2. Department of Medicine (220)
  3. Hematologic Malignancies, Division of (220)
  4. Lymphoma (220)
  5. Population Sciences Research Program (220)
  6. Survivorship Research (114)

More Groups

People
  1. Steven Horwitz (220)
  2. Andrew Zelenetz (102)
  3. Ariela Noy (99)
  4. Paul Hamlin (95)
  5. Maria Palomba (90)
  6. David Straus (89)

More People

Years
  1. 2025 (5)
  2. 2024 (14)
  3. 2023 (21)
  4. 2022 (13)
  5. 2021 (24)
  6. 2020 (24)

More Years

Publications
  1. Blood (92)
  2. Hematological Oncology (15)
  3. Journal of Clinical Oncology (15)
  4. Journal of the American Academy of Dermatology (12)
  5. Blood Advances (10)
  6. Blood Cancer Journal (8)

More Publications

Publishers
  1. American Society of Hematology (102)
  2. Wiley Blackwell (21)
  3. American Society of Clinical Oncology (15)
  4. Elsevier Inc. (12)
  5. Mosby Elsevier (12)
  6. Nature Publishing Group (11)

More Publishers

Results (220)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic profiling of mantle cell lymphoma suggests poor-risk profile is present at diagnosis and does not arise by tumor evolution
    Meeting Abstract

    Joffe, E.; Kumar, A.; Zheng, S.; Uppal, M.; Bantilan, K. S.; Atteberry, P.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Genomic profiling of mantle cell lymphoma suggests poor-risk profile is present at diagnosis and does not arise by tumor evolution
    Meeting Abstract

    Joffe, E.; Kumar, A.; Zheng, S.; Uppal, M.; Bantilan, K. S.; Atteberry, P.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Outcomes and prognostic factors in African American/Black patients with mycosis fungoides and Sézary syndrome
    Meeting Abstract

    Geller, S.; Lebowitz, E.; Pulitzer, M. P.; Horwitz, S. M.; Moskowitz, A. J.; Dusza, S.; Myskowski, P. L.
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin
    Journal Article

    Kheterpal, M. K.; Dai, J.; Geller, S.; Pulitzer, M.; Ni, A.; Myskowski, P. L.; Moskowitz, A.; Kim, J.; Hong, E. K.; Fong, S.; more...
    Journal of the American Academy of Dermatology (2019)

    Fulltext@MSK | Save
  • Incidence and treatment outcomes of patients with transformed marginal zone lymphoma treated with RCHOP‐like regimens
    Meeting Abstract

    Rajeeve, S.; Bobillo, S. V.; Zelenetz, A. D.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; Moskowitz, A. J.; Hamlin, P. A.; Matasar, M. J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Phase I/II study of CHOEP plus lenalidomide as initial therapy for patients with stage II‐IV peripheral T‐cell lymphoma: Phase II results
    Meeting Abstract

    Lunning, M.; Horwitz, S.; Advani, R.; Vose, J.; Lee, H.; Mehta‐Shah, N.; Zain, J.; Haverkos, B.; Lechowicz, M.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Impact of pet imaging and histologic transformation on the prognosis of early disease progression in follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Hamlin, P.; Horwitz, S. M.; Kumar, A.; Matasar, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Duvelisib, an oral dual PI3K‐δ,γ inhibitor, efficacy and safety in patients with relapsed or refractory (RR) peripheral T‐cell lymphoma: Rationale for the phase 2 PRIMO trial
    Meeting Abstract

    Horwitz, S. M.; Foss, F. M.; Porcu, P.; Moskowitz, A.; Mehta‐Shah, N.; Jacobsen, E.; Khodadoust, M. S.; Kim, Y. H.; Weinstock, D.; Lustgarten, S.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Treatment of Rosai–Dorfman disease with oral bexarotene: A case series
    Journal Article

    Geller, S.; Busam, K.; Hamlin, P. A.; Moskowitz, A. J.; Horwitz, S. M.; Myskowski, P. L.
    Journal of Dermatological Treatment (2019)

    Fulltext@MSK | Save